D-0898-2021 Class II Terminated

Recalled by SigmaPharm Laboratories LLC — Bensalem, PA

FDA drug recall D-0898-2021 was initiated by SigmaPharm Laboratories LLC on Sep 21, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing. The recall status is terminated (terminated Sep 26, 2022). Affected quantity: 1192 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 6, 2021
Initiation Date
Sep 21, 2021
Termination Date
Sep 26, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1192 bottles

Product description

Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53 mm CRC caps packed in a carton and then in case packs containing 2 bottles. Sigmapharm Laboratories, LLC, Bensalem, PA 19020, NDC 42794-086-14

Reason for recall

Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.

Distribution pattern

Nationwide

Code information

Lots 2005401, 2005501, 2005601, 2005701, Exp FEB 2023; Lots 2101401, 2101501, Exp FEB-2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0898-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0898-2021. Report a data issue: hello@regdatalab.com.